Ibio Inc (NYSE American:IBIO)
| 0.3101 Delayed Data As of Oct 02 |  +0.0021 / +0.68%Today’s Change | 0.26 Today|||52-Week Range 4.53 | -30.22% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Other | MARKET CAP $8.3M |
Company Description
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. It focuses on the development of precision antibodies. The company was founded on April 17, 2008 and is headquartered in Bryan, TX.
Contact Information
iBio, Inc. 8800 HSC Parkway Bryan Texas 77807 |
Employees
Shareholders
| Mutual fund holders | 2.61% |
| Other institutional | 2.43% |
| Individual stakeholders | 1.50% |
Top Executives
| Martin B. Brenner | Chief Executive & Scientific Officer |
| Mike Jenkins | Vice President-Operations |
| Felipe Duran | Chief Financial Officer |
| Phan Dillon | Vice President, Head-Research & Development |
| Matthew Luter | Vice President-Information Technology |
